In a study of colorectal cancer, Yang et al. found that TIMP metallopeptidase inhibitor 1 (TIMP1) mRNA levels were elevated in platelets from patients compared to healthy individuals or those with inflammatory bowel diseases, indicating a potential as a diagnostic biomarker for colorectal cancer [58]. Here, TIMP1 is linked to inflammatory bowel disease.